Stage IV EGFR Mutation-Negative and ALK Mutation-Negative Lung Adenocarcinoma: Long-Term Survival is Possible

Lung cancer is the leading cause of cancer death in the United States with a five-year survival of 16.8% for all stages and median survival of four months for Stage IV disease. We report a case of a 54-year-old male with a seven-year survival after being diagnosed with Stage IV epidermal growth fact...

Descripción completa

Detalles Bibliográficos
Autores principales: Kedia, Shiksha, Garcia, Gwenalyn, Dhar, Meekoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2015
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725754/
https://www.ncbi.nlm.nih.gov/pubmed/26835190
http://dx.doi.org/10.7759/cureus.419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4725754/
https://www.ncbi.nlm.nih.gov/pubmed/26835190
http://dx.doi.org/10.7759/cureus.419

Ejemplares similares